Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 23, 2015 11:02 AM ET

Life Sciences Tools and Services

Company Overview of The EMMES Corporation

Company Overview

The EMMES Corporation operates as a contract research organization. Its products include EMMES AdvantageEDC, a platform that provides study design tools and data collection in electronic case report forms and data quality management; EMMES RTS, a platform to assist in coordination, collection, organization, and retrieval of regulatory documentation for investigational sites; and EMMES GlobalTrace, a materials/specimen management platform that tracks in real-time from collection at a clinical site to arrival and storage at a central laboratory or repository. The company’s services include statistical leadership and project management, study design and protocol development, Web-based data coll...

401 North Washington Street

Suite 700

Rockville, MD 20850

United States

Founded in 1977

Phone:

301-251-1161

Fax:

301-251-1355

Key Executives for The EMMES Corporation

Chief Executive Officer and President
Chief Financial Officer and Vice President
Chief Medical Officer
Vice President
Vice President
Compensation as of Fiscal Year 2014.

The EMMES Corporation Key Developments

EMMES Corp. Wins $7.93 Million Federal Contract

EMMES Corp. won a federal contract from the U.S. Department of Health and Human Services' National Institutes of Health, Bethesda, Maryland, for research and development services. The agency said the contract had the following value: $7,929,947 plus six one-year term options (worth $53,415,968 total) plus quantity options to increase level-of-effort (worth $29,876,760 total) plus one a non-severable transition option (worth $2,345,909).

EMMES Corp. Wins $32,426,557 Federal Contract

EMMES Corp. won a $32,426,557 federal contract from the U.S. Department of Health and Human Services' National Institutes of Health, Rockville, Maryland, for services in support of the Central Institutional Review Board.

EMMES Corporation Wins $21.5 Million Federal Contract

EMMES Corp. won a federal contract valued at up to $21.5 million from the U.S. Department of Health and Human Services' National Institutes of Health, Bethesda, Maryland, for research and development services.

Similar Private Companies By Industry

Company Name Region
AMRI SSCI, LLC. United States
Summit Drug Development Services LLC United States
Knome, Inc. United States
Sofie Biosciences, Inc. United States
BioDTX, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The EMMES Corporation, please visit www.emmes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.